Adaptability and Resilience in Aging Adults-2
CompletedNot applicableNCT04068922
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic low back pain is a major health concern among older adults and is associated with increased economic, functional, and psychological burden. Resilience has been highlighted as a crucial factor in positive health-related functioning, and a growing body of literature supports the use of resilience-based interventions in chronic pain. Therefore, the goals of this project are to examine the feasibility and acceptability of a resilience intervention for chronic low back pain among older adults.
Study details
- Official title
- Adaptability and Resilience in Aging Adults-2
- Conditions
- Interventions
- Behavioral: Resilience Intervention
- Sponsor
- University of Florida
- Collaborators
- National Institute on Aging (NIA)
- Start date
- 2020-01-21
- Primary completion
- 2023-05-31
- Sex
- All
- Age range
- from 60 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 60 and older * Low back pain on at least half the days over the previous 6 months * Average daily back pain score ≥3 on a 0-10 numerical rating scale * At least moderate (≥3/10) CLBP-related interference on a 0-10 numerical rating scale * Able to read/write in English Exclusion Criteria: * Current participation in another psychological treatment * Severe psychiatric illness not adequately controlled by medication (e.g., schizophrenia, bipolar disorder) or other conditions anticipated to impair intervention engagement (e.g., substance abuse/dependence) * Presence of chronic, malignant pain (e.g., HIV, cancer) or systemic inflammatory disease (e.g., rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, etc.) * Significant cognitive impairment on the MoCA * If currently taking prescription analgesic or psychotropic medication, must be stabilized on these treatments for ≥4 weeks prior to the baseline assessment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04068922